Standard Operating Procedure for Prospective Individualised Dosimetry for [131] I-rituximab Radioimmunotherapy of Non-Hodgkin′s Lymphoma
Radioimmunotherapy (RIT) is an attractive therapy for non-Hodgkin′s lymphoma (NHL) as it allows targeted tumor irradiation which provides a cytotoxic effect significantly greater than that of the immune-mediated effects of a non-radioactive, or ′cold′, antibody alone. Anti-CD20 antibodies such as ri...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2012-07-01
|
| Rangatū: | World Journal of Nuclear Medicine |
| Ngā marau: | |
| Urunga tuihono: | http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.103409 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|